详情
Eotaxin Human Recombinant (CCL11)
目录号 | AP5640 |
---|---|
Physical Appearance | Sterile Filtered White lyophilized (freeze-dried) powder. |
Formulation | Lyophilized from a 0.2µm filtered concentrated (1.0mg/ml) solution in 20mM PB, pH 7.4, 150mM NaCl. |
Protein biological activity | The activity is determined by the chemoattract of human PBE (peripheral blood eosinophils) at a concentration between 0.1-10 ng/ml corresponding to a Specific Activity of 100,000-10,000,000IU/mg. |
Amino acid sequence | The sequence of the first five N-terminal amino acids was determined and was found to be Gly-Pro-Ala-Ser-Val. |
Uniprot ACC# | P51671 |
Purity | Greater than 97.0% as determined by:(a) Analysis by RP-HPLC.(b) Analysis by SDS-PAGE. |
Solubility | It is recommended to reconstitute the lyophilized Eotaxin Human Recombinant in sterile 18M??-cm H2O not less than 100µg/ml, which can then be further diluted to other aqueous solutions. |
Stability | Lyophilized Eotaxin although stable at room temperature for 3 weeks, should be stored desiccated below -18°C. Upon reconstitution CCL11 should be stored at 4°C between 2-7 days and for future use below -18°C.For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).Please prevent freeze-thaw cycles. |
Source | Escherichia Coli. |
Synonyms | Small inducible cytokine A11, CCL11, Eosinophil chemotactic protein, chemokine (C-C motif) ligand 11, SCYA11, MGC22554. |
Transportation method | Shipped at Room temp |
产品资料
产品标签
Product Questions
Product Questions
No Questions